Mologen executes three-for-one stock split
On Monday, October 2, 2000, Mologen Holding AG (Freiverkehr: MGN) will execute a three-for-one stock split. Mologen shareholders will receive three no par value shares with a stated par value of 1 Euro for every no par value share with a stated par value of 3 Euro held. Execution entails no costs for shareholders.
The share capital of Mologen Holding AG remains unchanged at 4,950,000 Euro. The number of stocks will increase from 1.65 million to 4.95 million.
Mologen is a research-driven company dedicated to developing tools and products for molecular medicine and bioinformatics. The proprietary MIDGE® technology is used in gene therapy and genetic vaccination.
Berlin, September 25, 2000
Board of Executives